Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Dual PDE IV/TNF inhibitors from Pfizer

Feb. 12, 1997

Neurotrophic rotamase inhibitors described by Guilford

Feb. 12, 1997

Antineoplastic retinoid compounds disclosed

Feb. 12, 1997

Merck Frosst discloses leukotriene antagonists

Feb. 12, 1997

AGE inhibitors reported by Alteon

Feb. 12, 1997

Anticonvulsants with favorable protection indices reported by Canadian researchers

Feb. 12, 1997

Teva presents potential antipsoriatic agents

Feb. 12, 1997

Diagnostic MAbs from Terumo

Feb. 11, 1997

Sumitomo develops ACAT inhibitors

Feb. 11, 1997

Eisai synthesizes heterocyclic anticancer compounds

Feb. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...